By elucidating the role of deleterious variants in IGHG1 and their association with HD, we aim to lay the foundation for developing targeted therapies and precision medicine approaches to mitigate the devastating impact of this debilitating disorder. This evidence concerns the gene IGHG1 and Huntington disease.